Resection of liver metastases from breast cancer: Estrogen receptor status and response to chemotherapy before metastasectomy define outcome

Surgery

Volumn 151, Issue 5, 2012, Pages 710-716

  Abbott, Daniel E ^a   Brouquet, Antoine ^a   Mittendorf, Elizabeth A ^a   Andreou, Andreas ^a   Meric Bernstam, Funda ^a   Valero, Vicente ^a   Green, Marjorie C ^a   Kuerer, Henry M ^a   Curley, Steven A ^a   Abdalla, Eddie K ^a   Hunt, Kelly K ^a   Vauthey, Jean Nicolas ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TRASTUZUMAB;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LIQUORRHEA; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; METASTASIS RESECTION; OVERALL SURVIVAL; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; PREDICTOR VARIABLE; PREOPERATIVE EVALUATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME;

ADULT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CHEMOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MASTECTOMY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84859795424     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2011.12.017     Document Type: Article

References (23)

1. Cancer Facts and Figures. American Cancer Society, 2010. Available from http://www.cancer.org/research/cancerfactsfigures/cancerfactsfigures/ cancer-facts-and-figures-2010.
2. M.F. Ernst, L.V. van de Poll-Franse, and J.A. Roukema Trends in the prognosis of patients with primary metastatic breast cancer diagnosed between 1975 and 2002 Breast 16 2007 344 351 (Pubitemid 47109194)
3. A.K. Imkampe, and T. Bates Improvements in breast cancer survival over time, related to adjuvant treatment and node status Eur J Surg Oncol 35 2009 151 155
4. J. Lubrano, H. Roman, and S. Tarrab Liver resection for breast cancer metastasis: does it improve survival? Surg Today 38 2008 293 299 (Pubitemid 351661111)
5. R. Adam, T. Aloia, and J. Krissat Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg 244 2006 897 907 (Pubitemid 44808622)
6. M. Selzner, M.A. Morse, and J.J. Vredenburgh Liver metastases from breast cancer: long-term survival after curative resection Surgery 127 2000 383 389 (Pubitemid 30225989)
7. L.E. Harrison, M.F. Brennan, and E. Newman Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients Surgery 121 1997 625 632 (Pubitemid 27251901)
8. M. Caralt, I. Bilbao, and J. Cortes Hepatic resection for liver metastases as part of the "oncosurgical" treatment of metastatic breast cancer Ann Surg Oncol 15 2008 2804 2810
9. D. Elias, F. Maisonnette, and M. Druet-Cabanac An attempt to clarify indications for hepatectomy for liver metastases from breast cancer Am J Surg 185 2003 158 164 (Pubitemid 36143907)
10. D. Elias, P.H. Lasser, and D. Montrucolli Hepatectomy for liver metastases from breast cancer Eur J Surg Oncol 21 1995 510 513
11. M. Yoshimoto, T. Tada, and M. Saito Surgical treatment of hepatic metastases from breast cancer Breast Cancer Res Treat 59 2000 177 184 (Pubitemid 30216141)
12. M. Pocard, P. Pouillart, and B. Asselain Hepatic resection for breast cancer metastases: results and prognosis (65 cases) [in French] Ann Chir 126 2001 413 420
13. J. Weitz, L.H. Blumgart, and Y. Fong Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma Ann Surg 241 2005 269 276
14. S.K. Reddy, A.S. Barbas, and C.E. Marroquin Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis J Am Coll Surg 204 2007 372 382 (Pubitemid 46283502)
15. K. Hoffmann, C. Franz, and U. Hinz Liver resection for multimodal treatment of breast cancer metastases: identification of prognostic factors Ann Surg Oncol 17 2010 1546 1554
16. R. Adam, L. Chiche, and T. Aloia Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model Ann Surg 244 2006 524 535
17. G. Vlastos, D.L. Smith, and S.E. Singletary Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases Ann Surg Oncol 11 2004 869 874
18. A. Riaz, K. Memon, and F.H. Miller Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlation J Hepatol 54 2011 695 704
19. D.J. Slamon, B. Leyland-Jones, and S. Shak Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 N Engl J Med 344 2001 783 792 (Pubitemid 32222155)
20. J. Hurley, P. Doliny, and I. Reis Docetaxel, cisplatin, and trastuzumab as primary systemic therapy for human epidermal growth factor receptor 2-positive locally advanced breast cancer J Clin Oncol 24 2006 1831 1838 (Pubitemid 46638980)
21. A.U. Buzdar, V. Valero, and N.K. Ibrahim Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized study population and data of additional patients treated with the same regimen Clin Cancer Res 13 2007 228 233 (Pubitemid 46121873)
22. O. Er, D.K. Frye, and S.W. Kau Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy Cancer J 14 2008 62 68
23. J.W. Zinser, G.N. Hortobagyi, A.U. Buzdar, T.L. Smith, and G. Fraschini Clinical course of breast cancer patients with liver metastases J Clin Oncol 5 1987 773 782 (Pubitemid 17120255)